摘要 |
This invention is directed to methods of treating diseases or conditions associated with JAK2 activity in a mammal comprising the administration of a compound of formula (I): where n, m, Y, R1, R2, R3, R4 and R5 are disclosed herein, or a pharmaceutically acceptable salt. |
申请人 |
RIGEL PHARMACEUTICALS, INC. |
发明人 |
BHAMIDIPATI, SOMASEKHAR;CLOUGH, JEFFREY;ARGADE, ANKUSH;SINGH, RAJINDER;MARKOVTSOV, VADIM;DING, PINGYU;YU, JIAXIN;ATUEGBU, ANDY;HONG, HUI;DARWISH, IHAB;THOTA, SAMBIAH |